Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-05A Randomized, Placebo-Controlled Trial of Hesperidin for Fatigue,Mood, and Cognitive Function in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-03Open-Label Rater-Blind Randomized Multi-Center Parallel-Arm Active- Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC Monthly vs. First Line DMT - Physician's Choice in the Treatment of Newly Diagnosed RMS
-
CLINICAL_TRIALS study record update · 2026-03-03The Effect of Exercise With and Without Cognitive Training on Gait in Older Veterans With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-02A Study of a New Assay to Detect Anti-drug Antibodies to Alemtuzumab and Their Potential Impact in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-27Development of Augmented Reality-Based Dual-Task Training to Enhance Cognitive and Motor Function in People With Multiple Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-27Dalfampridine Combined With Physical Therapy for Mobility Impairment in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-27Non-invasive Brain Stimulation for Altering Neuro-inflammatory Mediators of Central Fatigue in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-27A Phase 1, Open-Label, Single Center Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-27The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes
-
CLINICAL_TRIALS study record update · 2026-02-25A Pharmacokinetic, Safety and Tolerability Formulation Screening Comparing Corplex Ozanimod TDS to Oral Ozanimod Capsules in Healthy Adults Subjects
-
CLINICAL_TRIALS study record update · 2026-02-24Moving MS Bladder Dysfunction Into the 21st Century: Developing Novel and Accessible Ways to Treat Dysfunction in the Home - a Three Month Single Arm Open Label Feasibility Pilot With Waitlist Control
-
CLINICAL_TRIALS study record update · 2026-02-24Effectiveness and Feasibility of a Home-Based Exergame Rehabilitation Protocol for Upper Limb Function in Individuals With Multiple Sclerosis: A Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2026-02-23Amygdala Insula Retraining in the Management of Multiple Sclerosis Symptoms
-
CLINICAL_TRIALS study record update · 2026-02-23Investigating the Effects of Acute Intermittent Hypoxia on Neuroplasticity in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-23A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 Versus Placebo in Adults With Relapsing Multiple Sclerosis (ENSURE-1)
-
CLINICAL_TRIALS study record update · 2026-02-23Low-Load Resistance Training With Blood Flow Restriction in People With Multiple Sclerosis and Advanced Disability: A Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2026-02-23Exploring the Synergistic Effects of AIH and FES in Persons With MS
-
CLINICAL_TRIALS study record update · 2026-02-23A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-20Lead Exposure and Multiple Sclerosis;Biomarker Evidance and Clinical Impact.
-
CLINICAL_TRIALS study record update · 2026-02-20Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
-
CLINICAL_TRIALS study record update · 2026-02-20Relationship Between Pelvic Floor Dysfunctions and Core Endurance, Hip Rotation Muscle Strength, Tibialis Anterior and Tibialis Posterior Muscle Activation in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-20Central Vein Sign in Multiple Sclerosis Extension Study
-
CLINICAL_TRIALS study record update · 2026-02-20Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
-
CLINICAL_TRIALS study record update · 2026-02-19Investigation of the Effects of Education Provided Through Face-to-face and Tele-nursing Based on Pender's Health Promotion Model on Fatigue, Pain, Sleep, and Urinary Tract Infections ın Patients With Multiple Sclerosis: a Randomized Controlled Trial.
-
CLINICAL_TRIALS study record update · 2026-02-19Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)